CME Group 8-K
Earnings
Market data revenue hit a record, but higher expenses pushed operating income lower.
Filed 2026-07-22 07:15 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q2 2026 results. Revenue edged up Y/Y, while higher expenses coincided with lower operating income. Average daily volume was the third-highest quarterly total.
Key Figures
| Metric | Q2 2026 | Q2 2025 | Y/Y |
|---|---|---|---|
| Revenue | $1.71B | $1.69B | +0.8% |
| Operating income | $1.11B | $1.13B | -2.0% |
| Adjusted operating income, non-GAAP | $1.19B | $1.20B | -1.3% |
| Net income | $1.04B | $1.03B | +1.6% |
| Adjusted net income, non-GAAP | $1.08B | $1.08B | +0.2% |
| Diluted EPS | $2.88 | $2.81 | +2.5% |
| Adjusted diluted EPS, non-GAAP | $2.99 | $2.96 | +1.0% |
| Average daily volume | 29.8M contracts | 30.2M contracts | -1.2% |
- Market data revenue rose 20% to a record $238M; clearing and transaction fees were $1.35B, and the average rate per contract was $0.678.
- Cash was $2.3B, including $200M deposited with Fixed Income Clearing Corporation; debt was $3.4B. CME paid ≈$468M in dividends and repurchased $695M of shares. Weighted-average diluted shares were 361.3M vs 360.4M (+0.3%).
Guidance
No guidance in this filing.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3